FIGURE 1.

Incidence rate ratios of hypertension in participants receiving INSTI‐based regimens versus those on NNRTIs (a) or PIs (b)

Note: The final multivariable model was adjusted for the nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) backbone, age, ethnicity, sex, mode of transmission, calendar year, estimated glomerular filtration rate, smoking, body mass index, diabetes mellitus, prior AIDS, cardiovascular disease, hepatitis B and hepatitis C virus status, HIV RNA, nadir, and baseline CD4 counts, time since HIV diagnosis, baseline blood pressure and lipid levels, lipid‐lowering therapy, and prior ART (in the analysis for all people living with HIV). Abbreviations: ART, antiretroviral therapy; CI, confidence interval; INSTI, integrase strand transfer inhibitor; NNRTI, non‐nucleoside reverse transcriptase inhibitor; PI, protease inhibitor; PLWH, people living with HIV